BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 31619203)

  • 21. [A case of large cell neuroendocrine carcinoma of the rectum].
    Muto M; Ichiki K; Muto M; Ishikawa C; Inoue M; Aoki T; Hashimoto M; Inaba S; Yamamoto M
    Nihon Shokakibyo Gakkai Zasshi; 2015 Apr; 112(4):683-9. PubMed ID: 25843456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors.
    Collot T; Fumet JD; Klopfenstein Q; Vincent J; Bengrine L; Ghiringhelli F
    Anticancer Res; 2018 Oct; 38(10):5963-5968. PubMed ID: 30275226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation.
    Nojima H; Seike K; Kosugi C; Shida T; Koda K; Oda K; Kamata S; Ishikura H; Miyazaki M
    World J Surg Oncol; 2010 Apr; 8():29. PubMed ID: 20398400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].
    Gonda K; Tachiya Y; Hatakeyama Y; Shibata M; Kono K; Rokkaku Y
    Gan To Kagaku Ryoho; 2017 Oct; 44(10):944-946. PubMed ID: 29066704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of mixed adenoneuroendocrine carcinoma of the transverse colon].
    Kusakabe J; Miki A; Kobayashi H; Uryuhara K; Hashida H; Mizumoto M; Kaihara S; Hosotani R; Yamashita D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1826-8. PubMed ID: 25731343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A Case of Pathological Complete Response of Advanced Rectal Cancer with Direct Invasion of the Prostate and Extra-Regional Lymph Node Metastasis after Chemotherapy].
    Matsuzawa F; Homma S; Miyaoka Y; Yokoyama R; Nakano S
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1525-1527. PubMed ID: 38303329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of colorectal neuroendocrine carcinoma effectively treated with bevacizumab+levofolinate+5-FU chemotherapy].
    Yabuki H; Suto T; Inoue K; Fujimoto H; Sato T; Ikeda E; Iizawa H
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1139-42. PubMed ID: 22790056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of rectal neuroendocrine carcinoma:a report of 16 cases].
    Peng YF; Xue WC; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):170-3. PubMed ID: 19296255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine tumors of the rectum: a 10-year review of management.
    Moore JR; Greenwell B; Nuckolls K; Schammel D; Schisler N; Schammel C; Culumovic P; McKinley BP; Trocha SD
    Am Surg; 2011 Feb; 77(2):198-200. PubMed ID: 21337880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poorly differentiated neuroendocrine cell carcinoma of the rectum: report of a case and literal review.
    Miyamoto H; Kurita N; Nishioka M; Ando T; Tashiro T; Hirokawa M; Shimada M
    J Med Invest; 2006 Aug; 53(3-4):317-20. PubMed ID: 16953071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma.
    Hadoux J; Malka D; Planchard D; Scoazec JY; Caramella C; Guigay J; Boige V; Leboulleux S; Burtin P; Berdelou A; Loriot Y; Duvillard P; Chougnet CN; Déandréis D; Schlumberger M; Borget I; Ducreux M; Baudin E
    Endocr Relat Cancer; 2015 Jun; 22(3):289-98. PubMed ID: 25770151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.
    Choi GH; Ann SY; Lee SI; Kim SB; Song IH
    World J Gastroenterol; 2016 Nov; 22(41):9229-9234. PubMed ID: 27895410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinoma.
    Okita NT; Kato K; Takahari D; Hirashima Y; Nakajima TE; Matsubara J; Hamaguchi T; Yamada Y; Shimada Y; Taniguchi H; Shirao K
    Gastric Cancer; 2011 Jun; 14(2):161-5. PubMed ID: 21327441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus.
    Okuma HS; Iwasa S; Shoji H; Takashima A; Okita N; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y
    Anticancer Res; 2014 Sep; 34(9):5037-41. PubMed ID: 25202088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical resection after chemotherapy for advanced rectal cancer - report of a case].
    Suda K; Kameyama H; Shimada Y; Sakata J; Kobayashi T; Nogami H; Minagawa M; Kosugi S; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1572-4. PubMed ID: 25731256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irinotecan plus cisplatin followed by octreotide long-acting release maintenance treatment in advanced gastroenteropancreatic neuroendocrine carcinoma: IPO-NEC study.
    Li J; Lu M; Lu Z; Li Z; Liu Y; Yang L; Li J; Zhang X; Zhou J; Wang X; Gong J; Gao J; Li Y; Shen L
    Oncotarget; 2017 Apr; 8(15):25669-25678. PubMed ID: 27788498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poorly differentiated small-cell neuroendocrine carcinoma of the submandibular gland: a case report.
    Scaduto M; Matrka L; Shah M; Wakely P; Ozer E
    Ear Nose Throat J; 2012 Apr; 91(4):E10-3. PubMed ID: 22522359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effective chemotherapy with bevacizumab/FOLFOX4 for neuroendocrine carcinoma of the ascending colon - a case study].
    Tanabe H; Takase T; Morimoto D; Tanaka Y; Shibata A; Yaguchi T
    Gan To Kagaku Ryoho; 2014 May; 41(5):661-4. PubMed ID: 24917018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.